60 Minutes; April 1, 2012
"Is sugar toxic?" - Featuring Agios Co-founder Lewis Cantley, Ph.D.
Forbes; November 17, 2011
Why You Should Care That A Tiny Company Is Entering The Ultra-Rare Disease Market
Xconomy; October 11, 2011
"Agios and Celgene: Anatomy of an Ultra-Valuable Biotech Marriage"
Reuters; October 5, 2011
"Celgene pays $20 mln to extend Agios agreement"
Fierce Biotech; October 5, 2011
"Agios wins $20M haul as Celgene extends cancer development pact"
New York Times; November 1, 2010
"Fuel Lines of Tumors Are New Target"
Boston Business Journal; July 1, 2010
"Agios boosts staff following Celgene deal"
Boston Globe; April 20, 2010
"Celgene deal means $130m for Agios"
Reuters; April 10, 2010
"Celgene enters field of cancer cell metabolism"
Xconomy; April 5, 2010
"Celgene Pumps $130M Upfront into Agios Pharma for Drugs that Starve Cancer Cells"
Nature Reviews Cancer; January 1, 2010
"An oncogenic change of function"
Boston Globe; December 25, 2009
"Old discovery could bring new cancer therapies; How tumor cells use sugar may be key to their ability to grow"
Xconomy; December 15, 2009
"Agios, Seeking to Starve Cancer Cells to Death, Wins Support from Brain Tumor Foundation"
EPVantage; November 15, 2009
"Agios oncogene discovery casts spotlight on cancer metabolism"
Xconomy; May 25, 2009
"Agios Lands Genentech Cancer Drug Leader as New CEO"
BBC; January 25, 2009
"Genetic clue to glioma brain cancer growth"
Xconomy; November 25, 2008
"Agios Pharmaceuticals Forges Ahead With Lab to Starve Cancer Cells"